دورية أكاديمية

Rapid assembly of SARS-CoV-2 genomes reveals attenuation of the Omicron BA.1 variant through NSP6.

التفاصيل البيبلوغرافية
العنوان: Rapid assembly of SARS-CoV-2 genomes reveals attenuation of the Omicron BA.1 variant through NSP6.
المؤلفون: Taha TY; Gladstone Institutes, San Francisco, CA, USA. taha.taha@gladstone.ucsf.edu., Chen IP; Gladstone Institutes, San Francisco, CA, USA.; Department of Medicine, University of California, San Francisco, CA, USA., Hayashi JM; Gladstone Institutes, San Francisco, CA, USA., Tabata T; Gladstone Institutes, San Francisco, CA, USA., Walcott K; Gladstone Institutes, San Francisco, CA, USA., Kimmerly GR; Gladstone Institutes, San Francisco, CA, USA., Syed AM; Gladstone Institutes, San Francisco, CA, USA.; Innovative Genomics Institute, University of California, Berkeley, CA, USA., Ciling A; Gladstone Institutes, San Francisco, CA, USA.; Innovative Genomics Institute, University of California, Berkeley, CA, USA., Suryawanshi RK; Gladstone Institutes, San Francisco, CA, USA., Martin HS; Gladstone Institutes, San Francisco, CA, USA.; Department of Chemistry, University of California, Berkeley, CA, USA., Bach BH; Innovative Genomics Institute, University of California, Berkeley, CA, USA., Tsou CL; Gladstone Institutes, San Francisco, CA, USA., Montano M; Gladstone Institutes, San Francisco, CA, USA., Khalid MM; Gladstone Institutes, San Francisco, CA, USA., Sreekumar BK; Gladstone Institutes, San Francisco, CA, USA., Renuka Kumar G; Gladstone Institutes, San Francisco, CA, USA., Wyman S; Innovative Genomics Institute, University of California, Berkeley, CA, USA., Doudna JA; Gladstone Institutes, San Francisco, CA, USA.; Innovative Genomics Institute, University of California, Berkeley, CA, USA.; Department of Chemistry, University of California, Berkeley, CA, USA.; Department of Molecular and Cell Biology, University of California, Berkeley, CA, USA.; Howard Hughes Medical Institute, University of California, Berkeley, CA, USA.; Molecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.; California Institute for Quantitative Biosciences (QB3), University of California, Berkeley, CA, USA., Ott M; Gladstone Institutes, San Francisco, CA, USA. melanie.ott@gladstone.ucsf.edu.; Department of Medicine, University of California, San Francisco, CA, USA. melanie.ott@gladstone.ucsf.edu.; Chan Zuckerberg Biohub - San Francisco, San Francisco, CA, USA. melanie.ott@gladstone.ucsf.edu.
المصدر: Nature communications [Nat Commun] 2023 Apr 21; Vol. 14 (1), pp. 2308. Date of Electronic Publication: 2023 Apr 21.
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
أسماء مطبوعة: Original Publication: [London] : Nature Pub. Group
مواضيع طبية MeSH: Coronavirus Nucleocapsid Proteins*/genetics , COVID-19* , SARS-CoV-2*/genetics, Animals ; Genome, Viral/genetics ; RNA, Viral/genetics ; Subgenomic RNA/genetics
مستخلص: Although the SARS-CoV-2 Omicron variant (BA.1) spread rapidly across the world and effectively evaded immune responses, its viral fitness in cell and animal models was reduced. The precise nature of this attenuation remains unknown as generating replication-competent viral genomes is challenging because of the length of the viral genome (~30 kb). Here, we present a plasmid-based viral genome assembly and rescue strategy (pGLUE) that constructs complete infectious viruses or noninfectious subgenomic replicons in a single ligation reaction with >80% efficiency. Fully sequenced replicons and infectious viral stocks can be generated in 1 and 3 weeks, respectively. By testing a series of naturally occurring viruses as well as Delta-Omicron chimeric replicons, we show that Omicron nonstructural protein 6 harbors critical attenuating mutations, which dampen viral RNA replication and reduce lipid droplet consumption. Thus, pGLUE overcomes remaining barriers to broadly study SARS-CoV-2 replication and reveals deficits in nonstructural protein function underlying Omicron attenuation.
(© 2023. The Author(s).)
التعليقات: Update of: bioRxiv. 2023 Feb 09;:. (PMID: 36798416)
References: J Virol. 2002 Nov;76(21):11065-78. (PMID: 12368349)
Nat Med. 2022 Mar;28(3):481-485. (PMID: 35051990)
Nat Commun. 2022 Oct 7;13(1):5929. (PMID: 36207334)
Emerg Infect Dis. 2022 Jul;28(7):1442-1445. (PMID: 35551714)
ACS Synth Biol. 2022 Jun 17;11(6):2036-2042. (PMID: 35613368)
Science. 2021 Nov 26;374(6571):1099-1106. (PMID: 34648371)
Front Immunol. 2021 Jul 07;12:708264. (PMID: 34305949)
Nature. 2020 Dec;588(7838):498-502. (PMID: 32805734)
Sci Adv. 2023 Mar 29;9(13):eade8778. (PMID: 36989354)
J Med Virol. 2022 Aug;94(8):3739-3749. (PMID: 35467028)
Science. 2022 Jul 22;377(6604):428-433. (PMID: 35737809)
Clin Infect Dis. 2022 Aug 24;75(1):e289-e292. (PMID: 35353885)
Cell. 2022 Jul 7;185(14):2422-2433.e13. (PMID: 35772405)
Sci Immunol. 2021 Mar 4;6(57):. (PMID: 33664060)
Nature. 2023 Mar;615(7950):143-150. (PMID: 36630998)
J Exp Med. 2005 Jun 6;201(11):1741-52. (PMID: 15939790)
Nat Protoc. 2021 Mar;16(3):1761-1784. (PMID: 33514944)
Proc Natl Acad Sci U S A. 2021 Jul 20;118(29):. (PMID: 34292871)
PLoS Pathog. 2021 Aug 23;17(8):e1009849. (PMID: 34424945)
Cell Res. 2022 May;32(5):498-500. (PMID: 35292745)
Cell. 2022 Jun 9;185(12):2103-2115.e19. (PMID: 35568035)
Cell. 2021 Dec 9;184(25):6022-6036.e18. (PMID: 34838159)
PLoS One. 2020 Sep 2;15(9):e0238592. (PMID: 32877448)
Nat Med. 2022 Jul;28(7):1501-1508. (PMID: 35725921)
Cell Rep. 2022 Sep 13;40(11):111359. (PMID: 36075211)
Nat Commun. 2021 Jun 8;12(1):3431. (PMID: 34103499)
Cell Rep. 2021 Apr 20;35(3):109014. (PMID: 33838744)
Nature. 2022 Feb;602(7898):654-656. (PMID: 35016196)
PLoS Pathog. 2021 Mar 12;17(3):e1009439. (PMID: 33711082)
Nature. 2022 Mar;603(7902):706-714. (PMID: 35104837)
Nature. 2022 Aug;608(7923):593-602. (PMID: 35714668)
Nat Commun. 2021 Jul 30;12(1):4629. (PMID: 34330917)
Nature. 1990 Aug 16;346(6285):629-33. (PMID: 1696684)
Mol Cell Biol. 1984 Dec;4(12):2876-82. (PMID: 6549346)
Nat Microbiol. 2022 Aug;7(8):1161-1179. (PMID: 35798890)
Science. 2021 Apr 9;372(6538):. (PMID: 33658326)
Cell Host Microbe. 2022 Nov 9;30(11):1512-1517.e4. (PMID: 36108630)
Nature. 2022 Jun;606(7915):761-768. (PMID: 35551511)
mBio. 2020 Sep 25;11(5):. (PMID: 32978313)
Lancet. 2022 Jan 29;399(10323):437-446. (PMID: 35065011)
Cell. 2020 Oct 29;183(3):730-738.e13. (PMID: 32979942)
Signal Transduct Target Ther. 2022 Feb 10;7(1):45. (PMID: 35145066)
Cell Host Microbe. 2020 Sep 9;28(3):475-485.e5. (PMID: 32735849)
Cell. 2022 Oct 13;185(21):3992-4007.e16. (PMID: 36198317)
Cell Host Microbe. 2020 May 13;27(5):841-848.e3. (PMID: 32289263)
Virol Sin. 2021 Oct;36(5):913-923. (PMID: 33999369)
Nature. 2022 Feb;602(7898):657-663. (PMID: 35016194)
J Med Virol. 2022 Jul;94(7):3017-3031. (PMID: 35324008)
Front Microbiol. 2022 Jun 01;13:907422. (PMID: 35722274)
Emerg Microbes Infect. 2022 Dec;11(1):1-5. (PMID: 34890524)
J Travel Med. 2020 Mar 13;27(2):. (PMID: 32052846)
Nature. 2022 Mar;603(7902):700-705. (PMID: 35104835)
Nat Microbiol. 2020 Apr;5(4):536-544. (PMID: 32123347)
mBio. 2023 Feb 28;14(1):e0281522. (PMID: 36625640)
Nat Commun. 2022 Jul 27;13(1):4337. (PMID: 35896528)
Virology. 1995 Dec 20;214(2):611-8. (PMID: 8553563)
Microbiol Spectr. 2023 Mar 6;:e0338522. (PMID: 36877070)
Nature. 2022 Mar;603(7902):687-692. (PMID: 35062015)
Science. 2021 Apr 16;372(6539):. (PMID: 33688063)
Nature. 2001 Jul 19;412(6844):334-8. (PMID: 11460164)
PLoS Biol. 2021 Feb 25;19(2):e3001091. (PMID: 33630831)
Mol Biol Evol. 2022 Apr 11;39(4):. (PMID: 35325204)
J Travel Med. 2021 Oct 11;28(7):. (PMID: 34369565)
Science. 2021 Dec 24;374(6575):1626-1632. (PMID: 34735219)
Nat Rev Microbiol. 2023 Mar;21(3):162-177. (PMID: 36653446)
Virol J. 2022 Apr 26;19(1):76. (PMID: 35473640)
Nature. 2022 Jul;607(7917):119-127. (PMID: 35576972)
Nature. 2020 Jul;583(7816):459-468. (PMID: 32353859)
Clin Infect Dis. 2022 Aug 03;:. (PMID: 35917440)
Med. 2022 Apr 8;3(4):262-268.e4. (PMID: 35313451)
Nature. 2022 Mar;603(7902):693-699. (PMID: 35062016)
معلومات مُعتمدة: U19 AI171110 United States AI NIAID NIH HHS; F31 AI164671 United States AI NIAID NIH HHS
المشرفين على المادة: 0 (Coronavirus Nucleocapsid Proteins)
0 (NSP6 protein, SARS-CoV-2)
0 (RNA, Viral)
0 (Subgenomic RNA)
SCR Organism: SARS-CoV-2 variants
تواريخ الأحداث: Date Created: 20230421 Date Completed: 20231016 Latest Revision: 20231016
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC10120482
DOI: 10.1038/s41467-023-37787-0
PMID: 37085489
قاعدة البيانات: MEDLINE
الوصف
تدمد:2041-1723
DOI:10.1038/s41467-023-37787-0